首页> 美国卫生研究院文献>Frontiers in Immunology >Heat Shock Protein 70 Serum Levels Differ Significantly in Patients with Chronic Hepatitis Liver Cirrhosis and Hepatocellular Carcinoma
【2h】

Heat Shock Protein 70 Serum Levels Differ Significantly in Patients with Chronic Hepatitis Liver Cirrhosis and Hepatocellular Carcinoma

机译:慢性肝炎肝硬化和肝细胞癌患者的热休克蛋白70血清水平明显不同

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Members of the heat shock protein 70 (HSP70) family play an important role in assisting protein folding, preventing protein aggregation and transport of proteins across membranes under physiological conditions. Following environmental (i.e., irradiation, chemotherapy), physiological (i.e., cell growth, differentiation), and pathophysiological (i.e., inflammation, tumorigenesis) stress, the synthesis of heat shock proteins (HSPs) is highly up-regulated, whereas protein synthesis in general is reduced. In contrast to normal cells, many tumor entities including hepatocellular carcinoma (HCC) overexpress HSP70, the major-stress-inducible member of the HSP70 family, present it on their cell surface and secrete it into the extracellular milieu. Herein, the prognostic relevance of serum HSP70 levels in patients with chronic hepatitis (CH; n = 50), liver cirrhosis (LC; n = 46), and HCC (n = 47) was analyzed. Similar to other tumor entities, HSP70 is also present on the surface of primary HCC cells. The staining intensity of intracellular HSP70 in HCC tissue is stronger compared to control and cirrhotic liver sections. HSP70 serum levels in all HCC patients were significantly higher compared to a control group without liver disease (n = 40). No significant age- and gender-related differences in HSP70 serum levels were observed in male and female healthy human volunteers (n = 86). Patients with CH (n = 50) revealed significantly higher HSP70 serum levels compared to the control group, however, these values were significantly lower than those of HCC patients (n = 47). Furthermore, a subgroup of patients with LC who subsequently developed HCC (LC-HCC, n = 13) revealed higher HSP70 serum levels than patients with LC (n = 46, p = 0.05). These data indicate that serum HSP70 levels are consecutively increased in patients with CH, LC and liver carcinomas and thus might have a prognostic value.
机译:热休克蛋白70(HSP70)家族的成员在生理条件下协助蛋白质折叠,防止蛋白质聚集和蛋白质跨膜运输方面起着重要作用。在受到环境(即辐射,化学疗法),生理(即细胞生长,分化)和病理生理(即炎症,肿瘤发生)压力后,热休克蛋白(HSP)的合成高度上调,而蛋白质的合成一般减少。与正常细胞相比,包括肝细胞癌(HCC)在内的许多肿瘤实体过表达HSP70(HSP70家族的主要应激诱导成员),将其呈现在细胞表面并分泌到细胞外环境中。在此,分析了血清HSP70水平在慢性肝炎(CH; n = 50),肝硬化(LC; n = 46)和HCC(n = 47)患者中的预后相关性。与其他肿瘤实体相似,HSP70也存在于原代HCC细胞的表面。与对照和肝硬化肝切片相比,肝癌组织中细胞内HSP70的染色强度更强。与无肝病的对照组相比,所有HCC患者的HSP70血清水平均显着更高(n = 40)。在男性和女性健康人类志愿者中,未观察到HSP70血清水平与年龄和性别相关的显着差异(n = 86)。 CH患者(n = 50)显着高于对照组,但HSP70血清水平明显高于HCC患者(n = 47)。此外,随后发展为HCC的一部分LC患者(LC-HCC,n = 13)比LC患者的HSP70血清水平更高(n = 46,p = 0.05)。这些数据表明,CH,LC和肝癌患者的血清HSP70水平连续升高,因此可能具有预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号